January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

yahoo.com

Ratio Therapeutics Secures $50M Series B To Develop Cancer …

6 days from now

Jan 18, 2024  · Photo: Shutterstock. Boston-based pharmaceutical company Ratio Therapeutics has announced the completion of a $50 million Series B financing round to advance its …

builtinboston.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

prnewswire.com

Ratio Therapeutics Secures Funds For Cancer Radiotherapies

6 days from now

Jan 18, 2024  · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …

pharmaceutical-technology.com

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

6 days from now

Jan 17, 2024  · Funding Round. Series B - Ratio Therapeutics . Save . Summary. Overview. ... Built In — Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments . ...

crunchbase.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

biospace.com

Ratio Therapeutics Raises $50M In Series B Financing - FinSMEs

6 days from now

Jan 19, 2024  · Ratio Therapeutics, a Boston, MA-based pharmaceutical company, raised $50M in Series B funding. The round, which brought the total amount to $90M, was led by …

finsmes.com

Ratio Therapeutics Raises $50M In Series B Financing

6 days from now

Jan 17, 2024  · In July 2023, Ratio began studying its FAP-targeted, Cu-64-labeled radiopharmaceutical, RTX-1363S, in a Phase I trial in healthy volunteers. According to a …

precisionmedicineonline.com

Ratio Therapeutics Secures $50M In Series B Round Funding

6 days from now

Jan 19, 2024  · Boston-based Ratio Therapeutics secures $50M in series B round funding, bringing the total raised to date to over $90 million. The latest round witnessed continued …

startuprise.io

Media - Ratio Therapeutics

6 days from now

Oct 23, 2024  · Boston’s Ratio Therapeutics Raises $50M Series B For R&D. Law360 | January 17th, 2024. Pharmaceutical startup Ratio Therapeutics has raised a fresh round of funding, the …

ratiotx.com

Ratio Therapeutics Scores $50M Series B - VC News Daily

6 days from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

vcnewsdaily.com

Ratio Therapeutics - Crunchbase Company Profile & Funding

6 days from now

Ratio Therapeutics may be growing as evidenced by its recent $50 million Series B financing, which is aimed at advancing targeted radiotherapies for cancer treatment. Additionally, the …

crunchbase.com

Series B - Ratio Therapeutics - 2024-01-17 - Recent News

6 days from now

Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …

crunchbase.com

Ratio Therapeutics Closes $50M Series B Financing - Citybiz

6 days from now

Jan 17, 2024  · Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and …

citybiz.co

Novartis Strengthens Radiopharma Leadership With Ratio …

6 days from now

3 days ago  · Earlier this year, Ratio secured $50m in Series B funding to accelerate the platforms’ development. In the announcement accompanying the deal, Novartis’ president of biomedical …

pharmaceutical-technology.com

Ratio Therapeutics Raises $50M In Series B Financing

6 days from now

Ratio Therapeutics Raises $50M in Series B Financing 24-01-19 07:09:10 Ratio Therapeutics, a Boston, MA-based pharmaceutical company, raised $50M in Series B funding. The round, …

blockool.com

Built In Boston On LinkedIn: Ratio Therapeutics Secures $50M …

6 days from now

Pharmaceutical company Ratio Therapeutics plans to advance its first cancer therapy candidate into clinical trials following a new round of #funding. ... Ratio Therapeutics Secures $50M …

linkedin.com

858 Therapeutics Secures $50 Million In Series B Funding

6 days from now

Sep 27, 2024  · San Diego start-up 858 Therapeutics has raised $50 million in a Series B round led by Avidity Partners, with participation from new and existing investors. The funds will …

thepharmaletter.com